179 related articles for article (PubMed ID: 11742530)
1. Processing of proSAAS in neuroendocrine cell lines.
Mzhavia N; Qian Y; Feng Y; Che FY; Devi LA; Fricker LD
Biochem J; 2002 Jan; 361(Pt 1):67-76. PubMed ID: 11742530
[TBL] [Abstract][Full Text] [Related]
2. Tissue distribution and processing of proSAAS by proprotein convertases.
Sayah M; Fortenberry Y; Cameron A; Lindberg I
J Neurochem; 2001 Mar; 76(6):1833-41. PubMed ID: 11259501
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of ProSAAS: similarities and differences with 7B2.
Fortenberry Y; Hwang JR; Apletalina EV; Lindberg I
J Biol Chem; 2002 Feb; 277(7):5175-86. PubMed ID: 11719503
[TBL] [Abstract][Full Text] [Related]
4. The SAAS granin exhibits structural and functional homology to 7B2 and contains a highly potent hexapeptide inhibitor of PC1.
Cameron A; Fortenberry Y; Lindberg I
FEBS Lett; 2000 May; 473(2):135-8. PubMed ID: 10812060
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing.
Fricker LD; McKinzie AA; Sun J; Curran E; Qian Y; Yan L; Patterson SD; Courchesne PL; Richards B; Levin N; Mzhavia N; Devi LA; Douglass J
J Neurosci; 2000 Jan; 20(2):639-48. PubMed ID: 10632593
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of proprotein convertase SPC3 and the neuroendocrine precursor proSAAS.
Lanoue E; Day R
Endocrinology; 2001 Sep; 142(9):4141-9. PubMed ID: 11517193
[TBL] [Abstract][Full Text] [Related]
7. Distribution of proSAAS-derived peptides in rat neuroendocrine tissues.
Feng Y; Reznik SE; Fricker LD
Neuroscience; 2001; 105(2):469-78. PubMed ID: 11672612
[TBL] [Abstract][Full Text] [Related]
8. ProSAAS processing in mouse brain and pituitary.
Mzhavia N; Berman Y; Che FY; Fricker LD; Devi LA
J Biol Chem; 2001 Mar; 276(9):6207-13. PubMed ID: 11094058
[TBL] [Abstract][Full Text] [Related]
9. The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1.
Qian Y; Devi LA; Mzhavia N; Munzer S; Seidah NG; Fricker LD
J Biol Chem; 2000 Aug; 275(31):23596-601. PubMed ID: 10816562
[TBL] [Abstract][Full Text] [Related]
10. ProSAAS-derived peptides are differentially processed and sorted in mouse brain and AtT-20 cells.
Wardman JH; Fricker LD
PLoS One; 2014; 9(8):e104232. PubMed ID: 25148519
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory specificity and potency of proSAAS-derived peptides toward proprotein convertase 1.
Basak A; Koch P; Dupelle M; Fricker LD; Devi LA; Chrétien M; Seidah NG
J Biol Chem; 2001 Aug; 276(35):32720-8. PubMed ID: 11435430
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide mediated regulation of neuroendocrine associated proprotein convertases and neuropeptide precursor processing in the rat spleen.
Lansac G; Dong W; Dubois CM; Benlarbi N; Afonso C; Fournier I; Salzet M; Day R
J Neuroimmunol; 2006 Feb; 171(1-2):57-71. PubMed ID: 16337011
[TBL] [Abstract][Full Text] [Related]
13. Role of prohormone convertases in pro-neuropeptide Y processing: coexpression and in vitro kinetic investigations.
Brakch N; Rist B; Beck-Sickinger AG; Goenaga J; Wittek R; Bürger E; Brunner HR; Grouzmann E
Biochemistry; 1997 Dec; 36(51):16309-20. PubMed ID: 9405066
[TBL] [Abstract][Full Text] [Related]
14. Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway.
Eskeland NL; Zhou A; Dinh TQ; Wu H; Parmer RJ; Mains RE; O'Connor DT
J Clin Invest; 1996 Jul; 98(1):148-56. PubMed ID: 8690787
[TBL] [Abstract][Full Text] [Related]
15. Embryonic gene expression and pro-protein processing of proSAAS during rodent development.
Morgan DJ; Mzhavia N; Peng B; Pan H; Devi LA; Pintar JE
J Neurochem; 2005 Jun; 93(6):1454-62. PubMed ID: 15935061
[TBL] [Abstract][Full Text] [Related]
16. ProSAAS and prohormone convertase 1 are broadly expressed during mouse development.
Feng Y; Reznik SE; Fricker LD
Brain Res Gene Expr Patterns; 2002 Jan; 1(2):135-40. PubMed ID: 15018810
[TBL] [Abstract][Full Text] [Related]
17. Endoproteolytic processing of proopiomelanocortin and prohormone convertases 1 and 2 in neuroendocrine cells overexpressing prohormone convertases 1 or 2.
Zhou A; Mains RE
J Biol Chem; 1994 Jul; 269(26):17440-7. PubMed ID: 8021247
[TBL] [Abstract][Full Text] [Related]
18. Proglucagon processing in an islet cell line: effects of PC1 overexpression and PC2 depletion.
Dhanvantari S; Brubaker PL
Endocrinology; 1998 Apr; 139(4):1630-7. PubMed ID: 9528943
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide processing profile in mice lacking prohormone convertase-1.
Pan H; Nanno D; Che FY; Zhu X; Salton SR; Steiner DF; Fricker LD; Devi LA
Biochemistry; 2005 Mar; 44(12):4939-48. PubMed ID: 15779921
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of VGF peptides in rat brain. Role of PC1/3 and PC2 in the maturation of VGF precursor.
Trani E; Giorgi A; Canu N; Amadoro G; Rinaldi AM; Halban PA; Ferri GL; Possenti R; Schininà ME; Levi A
J Neurochem; 2002 May; 81(3):565-74. PubMed ID: 12065665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
